Skip to search formSkip to main contentSkip to account menu

Complamin

Known as: Riemser Brand of Xanthinol Niacinate, SmithKline Beecham Brand of Xanthinol Niacinate, Complamine 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Xanthinol Niacinate

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Über den Einfluß von Digitoxigenin auf das isolierte Actomyosin-Grana-System
1993
1993
Drug Monitoring Study (Phase IV) of Xantinolnicotinate (Complamin®) in General Practice
For 30 years, xantinolnicotinate has been on the market for the treatment of impaired brain function, i.e., organic brain… 
1990
1990
Efficacy of Xantinolnicotinate in Patients with Dementia
Activation of cerebral metabolism and improvement of microcirculation by influencing rheological parameters are claimed to be the… 
1985
1985
[Effect of complamine and nicospan on the cerebral blood flow and its regulation in changes in blood pressure].
Acute experiments on anesthetized cats under the conditions of artificial respiration were made to study the action of… 
1975
1975
Xanthinol nicotinate in peripheral vascular disease.
In a double-blind control of xanthinol nicotinate ('Complamin'; 'Complamex') in patients with severe progressive obliterative… 
1973
1973
The Effect of Oxygen Ventilation and a Vasodilator on Uterine Perfusion, Foetal Oxygen and Acid‐Base Balance
Uterine perfusion, the po2 in maternal ear capillary blood, the po2 and pH in portio blood, and the po2 PH, BE and pco2 in blood… 
1966
1966
Flaps and flap necrosis. Improving the circulation in skin flaps with Complamin and with Dicoumarol: animal experiments.
1965
1965
Studies with Complamin, a Nicotinic-acid/Theophylline Ester, as a Fibrinolytic Agent
Improvements in technique appear to allow endarterectomy to be performed below the inguinal ligament with a reasonable initial… 
1961
1961
[Experimental and clinical experiences with Complamine in disorders of cerebral and peripheral circulation].
1960
1960
[On the treatment of cerebral sclerosis with complamine].
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)